Cysteine Dioxygenase 1 Is a Tumor Suppressor Gene Silenced by Promoter Methylation in Multiple Human Cancers

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Brait, Mariana ^a,b   Ling, Shizhang ^a   Nagpal, Jatin K ^a   Chang, Xiaofei ^a   Park, Hannah Lui ^c   Lee, Juna ^a   Okamura, Jun ^a   Yamashita, Keishi ^d   Sidransky, David ^a   Kim, Myoung Sook ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER TUMOR; BREAST TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; CYSTEINE DIOXYGENASE 1 GENE; DNA METHYLATION; DOWN REGULATION; EMBRYO; ESOPHAGUS TUMOR; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG TUMOR; MOUSE; NEOPLASM; NONHUMAN; PROMOTER REGION; STOMACH TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE DIOXYGENASE; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC;

EID: 84866952731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044951     Document Type: Article

References (79)

1. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
2. Wolffe AP, Matzke MA, (1999) Epigenetics: regulation through repression. Science 286: 481-486.
3. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
4. Herman JG, Baylin SB, (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
5. Baylin SB, Herman JG, (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16: 168-174.
6. Paz MF, Fraga MF, Avila S, Guo M, Pollan M, et al. (2003) A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 63: 1114-1121.
7. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, et al. (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10: 3441-3454.
8. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, et al. (2004) A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 3: 28.
9. Satsu H, Terasawa E, Hosokawa Y, Shimizu M, (2003) Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells. Biochem J 375: 441-447.
10. Tsuboyama N, Hosokawa Y, Totani M, Oka J, Matsumoto A, et al. (1996) Structural organization and tissue-specific expression of the gene encoding rat cysteine dioxygenase. Gene 181: 161-165.
11. Oien DB, Moskovitz J, (2007) Ablation of the mammalian methionine sulfoxide reductase A affects the expression level of cysteine deoxygenase. Biochem Biophys Res Commun 352: 556-559.
12. Ueno K, Kumagai T, Kijima T, Kishimoto T, Hosoe S, (1998) Cloning and tissue expression of cDNAs from chromosome 5q21-22 which is frequently deleted in advanced lung cancer. Hum Genet 102: 63-68.
13. Staub E, Grone J, Mennerich D, Ropcke S, Klamann I, et al. (2006) A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 5: 37.
14. Tsuboyama-Kasaoka N, Hosokawa Y, Kodama H, Matsumoto A, Oka J, et al. (1999) Human cysteine dioxygenase gene: structural organization, tissue-specific expression and downregulation by phorbol 12-myristate 13-acetate. Biosci Biotechnol Biochem 63: 1017-1024.
15. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC, (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273: 3562-3573.
16. Bradley H, Gough A, Sokhi RS, Hassell A, Waring R, et al. (1994) Sulfate metabolism is abnormal in patients with rheumatoid arthritis. Confirmation by in vivo biochemical findings. J Rheumatol 21: 1192-1196.
17. Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, et al. (1990) Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett 110: 216-220.
18. Gregory WL, James OF, Idle JR, (1992) Carbocisteine polymorphism and disease. Lancet 339: 616-617.
19. El-Khairy L, Vollset SE, Refsum H, Ueland PM, (2003) Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 77: 467-472.
20. Karlsen RL, Pedersen OO, (1982) A morphological study of the acute toxicity of L-cysteine on the retina of young rats. Exp Eye Res 34: 65-69.
21. Booken N, Gratchev A, Utikal J, Weiss C, Yu X, et al. (2008) Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia 22: 393-399.
22. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, et al. (2008) Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 68: 2661-2670.
23. Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park HL, et al. (2009) Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 4: e6555.
24. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, et al. (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2: 485-495.
25. Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, et al. (2006) N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res 66: 3409-3418.
26. Kim MS, Chang X, Yamashita K, Nagpal JK, Baek JH, et al. (2008) Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene 27: 3624-3634.
27. Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, et al. (2010) Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 5: e9003.
28. Cho YG, Chang X, Park IS, Yamashita K, Shao C, et al. (2011) Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma. Int J Oncol 39: 337-344.
29. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
30. Maschietto M, Piccoli FS, Costa CM, Camargo LP, Neves JI, et al. (2011) Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour. Eur J Cancer.
31. Kwon YJ, Lee SJ, Koh JS, Kim SH, Lee HW, et al. (2011) Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer. J Thorac Oncol.
32. Dietrich D, Krispin M, Dietrich J, Fassbender A, Lewin J, et al. (2010) CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients. BMC Cancer 10: 247.
33. Mossman D, Scott RJ, (2011) Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. PLoS One 6: e23127.
34. Stipanuk MH, (2004) Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 24: 539-577.
35. Stipanuk MH, Ueki I, (2011) Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis 34: 17-32.
36. Stipanuk MH, Ueki I, Dominy JE Jr, Simmons CR, Hirschberger LL, (2009) Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels. Amino Acids 37: 55-63.
37. Davies MH, Ngong JM, Pean A, Vickers CR, Waring RH, et al. (1995) Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J Hepatol 22: 551-560.
38. Emery P, Salmon M, Bradley H, Wordsworth P, Tunn E, et al. (1992) Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ 305: 1387-1389.
39. Whiteman M, Haigh R, Tarr JM, Gooding KM, Shore AC, et al. (2010) Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann N Y Acad Sci 1203: 146-150.
40. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, et al. (2011) CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19: 387-400.
41. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
42. Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, et al. (2011) Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 301: E668-684.
43. Feng C, Tollin G, Enemark JH, (2007) Sulfite oxidizing enzymes. Biochim Biophys Acta 1774: 527-539.
44. Hildebrandt TM, Grieshaber MK, (2008) Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275: 3352-3361.
45. Huang J, Khan S, O'Brien PJ, (1998) The glutathione dependence of inorganic sulfate formation from L- or D-cysteine in isolated rat hepatocytes. Chem Biol Interact 110: 189-202.
46. Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, et al. (2011) Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal 15: 353-362.
47. Singh S, Padovani D, Leslie RA, Chiku T, Banerjee R, (2009) Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem 284: 22457-22466.
48. Chiku T, Padovani D, Zhu W, Singh S, Vitvitsky V, et al. (2009) H2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem 284: 11601-11612.
49. Chen X, Jhee KH, Kruger WD, (2004) Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem 279: 52082-52086.
50. Stipanuk MH, Beck PW, (1982) Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 206: 267-277.
51. Wang R, (2009) Hydrogen sulfide: a new EDRF. Kidney Int 76: 700-704.
52. Wagner CA, (2009) Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J Nephrol 22: 173-176.
53. Gallego D, Clave P, Donovan J, Rahmati R, Grundy D, et al. (2008) The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum. Neurogastroenterol Motil 20: 1306-1316.
54. Fiorucci S, Antonelli E, Mencarelli A, Orlandi S, Renga B, et al. (2005) The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42: 539-548.
55. Wang R, (2002) Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798.
56. Qu K, Lee SW, Bian JS, Low CM, Wong PT, (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52: 155-165.
57. Dominy JE, Stipanuk MH, (2004) New roles for cysteine and transsulfuration enzymes: production of H2S, a neuromodulator and smooth muscle relaxant. Nutr Rev 62: 348-353.
58. Kimura H, (2002) Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13-19.
59. Wallace JL, (2007) Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28: 501-505.
60. Li L, Bhatia M, Moore PK, (2006) Hydrogen sulphide-a novel mediator of inflammation? Curr Opin Pharmacol 6: 125-129.
61. Taniguchi S, Kang L, Kimura T, Niki I, (2011) Hydrogen sulphide protects mouse pancreatic beta-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br J Pharmacol 162: 1171-1178.
62. Schreier SM, Muellner MK, Steinkellner H, Hermann M, Esterbauer H, et al. (2010) Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox Res 17: 249-256.
63. Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, et al. (2010) Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 14: R165.
64. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, et al. (2010) Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122: 11-19.
65. Yao LL, Huang XW, Wang YG, Cao YX, Zhang CC, et al. (2010) Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol 298: H1310-1319.
66. Tiong CX, Lu M, Bian JS, (2010) Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Br J Pharmacol 161: 467-480.
67. Fang L, Li H, Tang C, Geng B, Qi Y, et al. (2009) Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats. Can J Physiol Pharmacol 87: 531-538.
68. Hu LF, Lu M, Wu ZY, Wong PT, Bian JS, (2009) Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 75: 27-34.
69. Blachier F, Davila AM, Mimoun S, Benetti PH, Atanasiu C, et al. (2010) Luminal sulfide and large intestine mucosa: friend or foe? Amino Acids 39: 335-347.
70. Di Rocco M, Caruso U, Briem E, Rossi A, Allegri AE, et al. (2006) A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation. Mol Genet Metab 89: 395-397.
71. Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, et al. (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15: 200-205.
72. Merinero B, Perez-Cerda C, Ruiz Sala P, Ferrer I, Garcia MJ, et al. (2006) Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. J Inherit Metab Dis 29: 685.
73. Cai WJ, Wang MJ, Ju LH, Wang C, Zhu YC, (2010) Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. Cell Biol Int 34: 565-572.
74. Deplancke B, Gaskins HR, (2003) Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 17: 1310-1312.
75. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC, (2006) Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 291: G288-296.
76. Robey RB, Hay N, (2009) Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19: 25-31.
77. Konami Y, Yamamoto K, Osawa T, Irimura T, (1995) A putative carbohydrate-binding domain of the lactose-binding Cytisus sessilifolius anti-H(O) lectin has a similar amino acid sequence to that of the L-fucose-binding Ulex europaeus anti-H(O) lectin. Glycoconj J 12: 128-134.
78. Crennell S, Garman E, Laver G, Vimr E, Taylor G, (1994) Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure 2: 535-544.
79. Fried M, Peskova M, (1993) [Short-term hospitalization and ambulatory care of patients with advanced hemorrhoidal disease]. Rozhl Chir 72: 173-175.